PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Research Center, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China.\', \'Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, 70 President Street, DDB410, Charleston, SC, 29425, USA.\', \'GenScript Biotech, Nanjing, 210003, China.\', \'Nanjing Infectious Disease Center, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China.\', \'Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.\', \'Department of Radiology, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China.\', \'Department of Laboratory Medicine, Nanjing Red Cross Blood Center, Nanjing, 210003, Jiangsu, China.\', \'Department of Clinical Laboratory, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China.\', \'Nanjing Infectious Disease Center, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China; Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166, China. Electronic address: huzhiliangseu@163.com.\', \'Nanjing Infectious Disease Center, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China. Electronic address: ian0126@126.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0753-3322(20)30822-210.1016/j.biopha.2020.110629
?:hasPublicationType
?:journal
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of
?:pmid
?:pmid
  • 33406577
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33406577>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33406577>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all